Cargando…
LARGE enzyme activity deciphered: a new therapeutic target for muscular dystrophies
A significant proportion of severe, inherited congenital muscular dystrophies are due to aberrant glycosylation of the extracellular matrix receptor α-dystroglycan and a consequent lack of ligand-binding activity. A key member of this glycosylation pathway is the LARGE protein, which was originally...
Autor principal: | Hewitt, Jane E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446273/ https://www.ncbi.nlm.nih.gov/pubmed/22458537 http://dx.doi.org/10.1186/gm322 |
Ejemplares similares
-
COL4A1 mutations: new route to congenital muscular dystrophy
Publicado: (2011) -
Highlight: The Social Code—Deciphering the Genetic Basis of Hymenopteran Social Behavior
por: McGrath, Casey
Publicado: (2023) -
Autophagy as a new therapeutic target in Duchenne muscular dystrophy
por: De Palma, C, et al.
Publicado: (2012) -
Autophagy as a new therapeutic target in Duchenne muscular dystrophy
por: De Palma, C, et al.
Publicado: (2013) -
Autophagy as a new therapeutic target in Duchenne muscular dystrophy
por: De Palma, C, et al.
Publicado: (2014)